PPD is a broad diagnostic category that describes a set of pathophysiologic processes affecting a woman after childbirth; these processes manifest as various somatic, emotional, and cognitive changes. These may include recurrent depressive symptoms such as sadness, anxiety, fatigue and disturbed sleep and appetite which may complicate a mother’s care for herself and her baby. PPD most commonly develops within the first year after birth but may occur at any time during the first postpartum year and may range from mild to severe. PPD should not be overlooked because its effects may significantly affect the mother and her child’s wellbeing and development, and stability of the family. The treatment required includes counseling, and supportive care, as well medication and therefore call for holistic approach and more awareness during postpartum period. PPD is a major mental health disorder which affects a substantial percentage of mothers and is manifested by profound emotional distress and fatigue that impairs a mother’s capacity to properly attend to herself and her newborn. The market for postpartum depression is one which has the potential to experience significant growth in the coming years, mainly due to increased understandings of the role that maternal mental health plays in the process of child rearing. It is for this reason that this market has got numerous treatment procedures such as drug treatment, therapy, and other treatment procedures to suit each woman experiencing PPD as discussed below. In addition, new pathways such as telehealth has ensured that woman can easily access the market hence enhancing the market growth.

The Smart Exoskeleton Market concerns this category or wearable robotic systems proposed for improving human physical abilities by means of sensors, actuators, or artificial intelligence.